TABLE 2.
Molecular tumor board drug selection
| Patient | Drug | Gene mutation | Gene overexpression |
|---|---|---|---|
| SL00402 | VORINOSTAT | HDAC2, HDAC4, HDAC9 | |
| SL00393 | VORINOSTAT | HDAC 2, HDAC8, RAD 23, CTBP2 | |
| SL00477 | VORINOSTAT | HDAC 2, HDAC9, CTBP2 | |
| SL00522 | CRIZOTINIB | ALK CVN gain | ALK |
| SL00511 | SORAFENIB | RET | |
| SL00535 | DASATINIB | PDGFRB, DDR2 | |
| SL00545 | VORINOSTAT | HDAC2 | |
| SL00558 | VORINOSTAT | HDAC2 | |
| SL00575 | VORINOSTAT | HDAC2 | |
| SL00581 | VORINOSTAT | HDAC2, HDAC9 | |
| SL00586 | VORINOSTAT | HDAC2, HDAC9 | |
| SL00587 | VORINOSTAT | HDAC2, HDAC9 | |
| SL00589 | VORINOSTAT | HDAC2, HDAC9 | |
| SL00605 | CRIZOTINIB | ALK SNV F1174L | ALK |
| SL00608 | VORINOSTAT | HDAC2, HDAC8, CTBP2 | |
| SL00625 | VORINOSTAT | HDAC2, HDAC9 | |
| SL00650 | VORINOSTAT | HDAC2 | |
| SL00653 | VORINOSTAT | HDAC2 | |
| SL00680 | VORINOSTAT | HDAC2 | |
| SL00720 | VORINOSTAT | HDAC2 |